.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
In young adults, the recurrence rate after a first traumatic anterior shoulder dislocation can be high enough to justify primary stabilization. This randomized clinical trial compared immediate arthroscopic repair with a conventional immobilization-and-rehabilitation pathway in patients younger than 30 years. At approximately two years, the surgically treated group had a substantially lower redislocation rate and better disease-specific quality-of-life measures, while range of motion was similar. The trial provided early evidence that recurrence prevention can be part of first-event management rather than a consequence of repeated failure. For clinicians, the practical implication is to identify patients at high recurrence risk early. Sporting activity, age, structural lesions and the direction of instability all influence the balance between surgery and observation. Patients should also understand that stabilization does not remove the need for rehabilitation. The study is especially relevant to young athletes because recurrent dislocation can lead to further labral and bony damage and can compromise return to sport. A shared decision should therefore weigh the up-front surgical burden against the potential to prevent recurrent instability.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
In young adults, the recurrence rate after a first traumatic anterior shoulder dislocation can be high enough to justify primary stabilization. This randomized clinical trial compared immediate arthroscopic repair with a conventional immobilization-and-rehabilitation pathway in patients younger than 30 years. At approximately two years, the surgically treated group had a substantially lower redislocation rate and better disease-specific quality-of-life measures, while range of motion was similar. The trial provided early evidence that recurrence prevention can be part of first-event management rather than a consequence of repeated failure. For clinicians, the practical implication is to identify patients at high recurrence risk early. Sporting activity, age, structural lesions and the direction of instability all influence the balance between surgery and observation. Patients should also understand that stabilization does not remove the need for rehabilitation. The study is especially relevant to young athletes because recurrent dislocation can lead to further labral and bony damage and can compromise return to sport. A shared decision should therefore weigh the up-front surgical burden against the potential to prevent recurrent instability.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
